Editor’s Note October 25, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies […]
Read more »Neovasc Aims For CE Mark in 2012
OneMedRadio interviewed Alexei Marko, CEO and Director of Neovasc [CVE:NVC] where he discussed the company’s products for treating heart disease. The company’s flagship product The Reducer is in late stage development.
Read more »This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »Editor’s Note October 17, 2011
As OneMedForum SF 2012 approaches, OneMedSentinel is on the lookout for some of the most promising companies and technologies, as […]
Read more »STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
Read more »Teribone Treats Osteoporosis With Noninvasive Systematic Approach
It was announced this week that Zosano Pharma, Inc. (Zosano) and Asahei Kasei Pharma (AKP) formed a collaboration to develop Teribone (teriparatide acetate), a transdermal patch treatment for osteoporosis.
Read more »This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »Inovio wins prestigious Edward Jenner Poster Award for cervical cancer vaccine research
Inovio Pharmaceuticals (AMEX:INO) won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer.
Read more »Promising Medical Technologies from Leading Universities to Showcase at 5th Annual OneMedForum
Significant Advances in Translational Medicine Result from “Coulter Process”.
Read more »